Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus.
CONCLUSION: Rebamipide treatment for 12 weeks improved atypical GI symptoms in patients with T2DM.
PMID: 27098506 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism Journal - Category: Endocrinology Tags: Diabetes Metab J Source Type: research
More News: Constipation | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Diabetic Ulcers | Endocrinology | Gastroenterology | Incontinence | Indigestion | Irritable Bowel Syndrome | Pain | Peptic Ulcer | Study